Lupin launches Favipiravir at Rs 49 to treat mild to moderate COVID-19 disease Lupin launches Favipiravir at Rs 49 to treat mild to moderate COVID-19 disease Pratik Shastri / Wednesday, August 5, 2020 0 1542 Article rating: 3.8 The newly-launched drug, which was the need of the hour, would be available in the form of a strip of ten tablets, marketed under the brand name of Covihalt. It will be used to treat patients having a mild to moderate COVID-19 disease. Read more
Sun Pharma launches FluGuard to treat mild to moderate COVID-19 disease Sun Pharma launches FluGuard to treat mild to moderate COVID-19 disease Pratik Shastri / Tuesday, August 4, 2020 0 1421 Article rating: 3.8 Favipiravir is the only oral anti-viral treatment approved in India for the potential treatment of patients with mild to moderate COVID-19 disease. Read more
Ind-Ra affirms Sagar Cements credit rating with stable outlook Ind-Ra affirms Sagar Cements credit rating with stable outlook Pratik Shastri / Tuesday, August 4, 2020 0 1954 Article rating: 4.4 Besides, to further expand in the Eastern region, the company had acquired Jaipur Cements in May 2019 to set up a grinding unit with 1.5 MTPA capacities at a cost of Rs 308 crore. Read more
SBI shares gain on strong advances growth SBI shares gain on strong advances growth Pratik Shastri / Friday, July 31, 2020 0 1638 Article rating: 4.4 The numbers show a very positive trend in the re-opening of the economy. Despite this, the bank added that the overall situation continues to be uncertain. One of the major challenges that the bank sees is the extended working capital cycle and waning cash flows. Read more
IEX: Electricity volume continues to rise; stock price near 52-week high IEX: Electricity volume continues to rise; stock price near 52-week high Pratik Shastri / Friday, July 31, 2020 0 2052 Article rating: 3.3 During the recently concluded Q1FY21, the company reported 14.5 per cent growth in electricity volumes at 14,878 MU in comparison to the same quarter last year. Read more